305 results on '"Decaens, T"'
Search Results
2. PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation
3. Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer
4. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool
5. Specific Functional Signature in Soil Macro-Invertebrate Biostructures
6. Liver-Targeted Disruption of Apc in Mice Activates β-Catenin Signaling and Leads to Hepatocellular Carcinomas
7. Dynamics of soil organic matter based on new Rock-Eval indices
8. Livret d’aide à l’éducation thérapeutique du patient recevant des chimiothérapies anticancéreuses intraveineuses et orales en oncologie digestive
9. 965MO Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line (1L) treatment for unresectable hepatocellular carcinoma (uHCC): Expanded analyses from CheckMate 9DW
10. 950P Outcomes by baseline tumour burden in EMERALD-1: A phase III, randomised, placebo (PBO)-controlled study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolisation (TACE) in participants (pts) with embolisation-eligible unresectable hepatocellular carcinoma (uHCC)
11. Tumeurs hépatocytaires bénignes : formes atypiques et pièges diagnostiques
12. Imaging benign hepatocellular tumors: Atypical forms and diagnostic traps
13. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
14. Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
15. Earthworm communities under an agricultural intensification gradient in Colombia
16. PD-020 Tolerability and activity of second-line tepotinib, a potent and highly selective c-MET inhibitor, in patients with advanced hepatocellular carcinoma previously treated with sorafenib
17. Abstract No. 117 A phase 3, double-blind, randomized study of nivolumab and Ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma
18. Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (British Journal of Cancer, (2021), 10.1038/s41416-021-01334-9)
19. Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer
20. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C
21. Liver-targeted disruption of Apc in mice activates [beta]-catenin signaling and leads to hepatocellular carcinomas
22. IMPACT OF CHEMOEMBOLIZATION WITH DOXORUBICIN LOADED BEADS (DC BEADS) IN PATIENTS AWAITING LIVER TRANSPLANTATION FOR HEPOCELLULAR CARCINOMA: FOS141
23. ONE HUNDRED LAPAROSCOPIC LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA COMPLICATING CHRONIC LIVER DISEASE: FOS162
24. THE UP TO SEVEN CRITERIA TRANSPOSED TO THE PRETRANSPLANT EVALUATION ARE LESS ACCURATE TO PREDICT RECURRENCE THAN GENUINE UP TO 7 BASED ON THE EXPLANT: BF122
25. DIFFUSION-WEIGHTED IMAGING AND18-F-FDG PET IN LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: TWO OF A KIND?: BF104
26. Pooled safety analysis of tepotinib in Asian patients with advanced solid tumours
27. Meeting Abstract: 745P
28. Biofunctool (R) : a new framework to assess the impact of land management on soil quality. Part A : concept and validation of the set of indicators
29. Effects of tropical endogeic earthworms on soil erosion
30. The impact of soil organisms on soil functioning under neotropical pastures: a case study of a tropical anecic earthworm species
31. Soil macrofaunal communities in permanent pastures derived from tropical forest or savanna
32. APPLICATION OF ALPHA-FETOPROTEIN AND OSTEOPONTIN COMBINATION FOR EARLY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA ASSOCIATED WITH HEPATITIS C
33. Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients
34. Safety profile of tepotinib in patients with advanced solid tumors: Pooled analysis of phase I and II data
35. Biomarkers in Diagnosis and Prediction of Hepatocellular Carcinoma Recurrence (Review)
36. Innovative multiplexed point-of-care immunoassay applied to hepatitis B screening
37. Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
38. CLINICAL AND EPIDEMIOLOGICAL MANIFESTATION OF HEPATOCELLULAR CARCINOMA IN PATIENTS BELONGING TO ETHNIC GROUPS OF CAUCASIANS AND ASIANS OF NORTH-EAST ASIA
39. CA209-9DX: Phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
40. Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib
41. Factors driving soil Collembola and earthworms in Mediterranean urban parks: feedbacks from Montpellier and Naples
42. gestion des sols et biodiversite
43. Phase II efficacy and safety data for the MET inhibitor tepotinib in patients (pts) with sorafenib-treated advanced hepatocellular carcinoma (HCC)
44. Practice patterns and deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): Final analysis of OPTIMIS in Europe and Canada
45. Mapeando os serviços ecossistêmicos em um contexto de frente pioneira : uma nova forma de interpretação dos territórios
46. 67P - Pooled safety analysis of tepotinib in Asian patients with advanced solid tumours
47. Effect of novel AKT inhibitor ARQ 751 as single agent and its combination with sorafenib on hepatocellular carcinoma in a cirrhotic rat model
48. Factors associated with tumor recurrence after liver transplantation for hepatocellular carcinoma: prospective cohort on 371 patients
49. AKT inhibitor ARQ 092 and sorafenib additively inhibit progression of hepatocellular carcinoma and improve immune system in cirrhotic rat model
50. 745P - Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.